Â鶹ʮÈýÅ®ÀÉ

Skip to Main Content

“He’s someone whose biggest strength is seeing the bigger picture and understanding clients objectives and setting a strategy.”

Chambers USA 2025

Overview

A former federal prosecutor, Jonathan counsels companies and individuals through their toughest and most complex legal situations.

Jonathan focuses on white collar criminal defense, federal investigations brought under the False Claims Act, and litigation against the government and whistleblowers, with an emphasis on matters within the healthcare industry. Clients nationwide seek Jonathan’s knowledge as a former federal prosecutor with extensive experience in both criminal and civil matters to guide them through federal investigations.

Chambers USA commends Jonathan as a “superstar,” “professional in every way,” with “a really incredible way of communicating,” and notes that “clients love him.” For federal investigations into healthcare companies, one client told Chambers USA that they “trusted his knowledge of the industry and the correct course to take,” and that Jonathan “always kept us informed.” Legal500 similarly extols Jonathan for “his deep knowledge of FCA federal investigations.”

Jonathan’s reputation as a top-tier trial lawyer and a leader in the healthcare enforcement community make him a go-to lawyer for any healthcare company under federal scrutiny.

At the U.S. Department of Justice, Jonathan earned a reputation as a top white collar prosecutor and trial lawyer. He was a key member of multiple international healthcare fraud takedowns and prosecuted a series of high-profile financial crime cases. Jonathan prosecuted doctors, lawyers, pharmacists, executives, and even a pastor for white collar crimes during his time as a federal prosecutor and was touted for his trial skills, with one federal judge calling Jonathan’s trial performance “masterful,” following a complex healthcare fraud trial. Jonathan also handled major civil investigations and litigation against companies and individuals under the False Claims Act and Controlled Substances Act, resulting in record-breaking settlements and judgments. For his work, Jonathan won some of the highest honors bestowed upon federal prosecutors by the DOJ, FBI, HHS-OIG, and DEA.

Jonathan now uses that experience to guide clients through federal investigations of all kinds, to litigate cases against and involving the government, and to run effective and right-sized internal investigations for corporations. Jonathan also advises clients on how to stay out of trouble with federal authorities, like the Drug Enforcement Administration, through proactive compliance measures. Many of the clients he serves are in the healthcare industry, including health systems, physician groups, and other healthcare companies, along with medical professionals and executives. But clients in all industries count on Jonathan to solve their toughest problems in creative, efficient, and reliable ways.

Jonathan is a leader in the white collar community and a frequent speaker on big-picture policy issues impacting healthcare enforcement, like the growing scope of enforcement under the Anti-Kickback Statute. Jonathan is also the host of Â鶹ʮÈýÅ®ÀÉ’s hit podcast False Claims Act Insights, which Law360 recently highlighted as one of the best podcasts for healthcare and life sciences lawyers. Jonathan also serves as a vice chair of the American Health Law Association’s Fraud and Abuse Practice Group and teaches white collar crime as an adjunct professor of law at Mercer University School of Law in Macon, Georgia.

“He’s someone whose biggest strength is seeing the bigger picture and understanding clients objectives and setting a strategy.”

Chambers USA 2025

Industries

Services

Recognition

  • Benchmark Litigation
    • Local Litigation Star, 2025
  • Chambers USA
    • Litigation: White Collar Crime & Government Investigations, 2025
  • The Legal 500 United States
    • Healthcare: Service providers, Recommended lawyer, 2024 and 2025
  • American Bar Foundation, Fellow
  • Southeastern Legal Awards (SLA) 2024 & 2025, Judging Panel
  • Council of the Inspectors General on Integrity and Efficiency (CIGIE) Award for Excellence, 2022
  • DOJ EOUSA Director’s Award, 2021
  • OIG Cooperative Achievement Award, Health and Human Services Office of Inspector General, 2021
  • Commendation for Demonstrated Excellence, Prosecutive Skills and Outstanding Services, FBI Director Christopher Wray, 2021

Education

  • J.D., Emory University School of Law
    • With Honors
    • Emory Law Journal, Articles Editor
  • M.P.A., Georgia Southern University
  • B.A., Furman University
    • Business Administration

Admissions

  • Georgia
  • U.S. District Court, Northern District of Georgia
  • U.S. District Court, Southern District of Georgia
  • U.S. District Court, Middle District of Georgia
  • U.S. District Court, District of Colorado
  • U.S. District Court, Western District of Wisconsin
  • U.S. District Court, Northern District of Texas
  • U.S. District Court, Southern District of Texas
  • U.S. District Court, Eastern District of Texas

Jonathan is associated with the Washington, DC office for telephone and mail purposes only. He is not admitted to practice in District of Columbia.

Professional Memberships and Certifications

  • American Bar Association, Antitrust Section
  • American Bar Association, Criminal Justice Section
  • American Bar Association, Healthcare Section
  • American Health Law Association
    • Vice Chair, Fraud & Abuse Practice Group
  • American College of Healthcare Executives, Georgia Chapter
  • Georgia Academy of Healthcare Attorneys​​​​
  • Georgia Bar Association, Health Law Section
  • Georgia Bar Association, Criminal Law Section


*Jonathan works remotely from Georgia, where he is licensed. Contact Jonathan via email or phone for in-person/virtual meetings. Use the Washington, DC office address for mail/deliveries only.

By working remotely through The Link, everything happens much more quickly – and Â鶹ʮÈýÅ®ÀÉ’s model of aligning by industry has made it easy for me to plug in.

Experience

Federal Investigation Defense

  • Defended federal investigation of healthcare provider, resulting in favorable settlement with Justice Department for repayment of funds, and no added penalties or multiplier.
  • Defended federal investigation of pharmacy accused of healthcare fraud, resulting in complete declination of all charges and closed investigation.
  • Defended federal investigation of healthcare executive for healthcare fraud and kickback conspiracy, resulting in complete declination of all charges and closed investigation.
  • Defended federal investigation of healthcare provider by DEA, resulting in complete declination of all charges and closed investigation.
  • Defended federal investigation of housing development company, resulting in complete declination of all charges and closed investigation.

Internal Investigations

  • Internal investigation on behalf of academic medical center relating to potential patient privacy issue.
  • Internal investigation on behalf of multi-state health system relating to alleged physician misconduct.
  • Internal investigation on behalf of health plan management company relating to Medicare billing practices.

Healthcare Compliance

  • Advised health system relating to HRSA program compliance.
  • Advised health system relating to Medicare billing practice compliance.
  • Advised physician group relating to Medicare billing practice compliance.
  • Advised physician group relating to complex Anti-Kickback Statute compliance.
Blog | July 02, 2025
Articles | June 26, 2025
Articles | May 2025
Articles | April 25, 2025
Articles | April 22, 2025
Articles | March 27, 2025
Blog | March 14, 2025
Blog | February 27, 2025
Articles | February 11, 2025
Articles | February 10, 2025
Articles | February 05, 2025
Blog | January 09, 2025
Articles | December 11, 2024
Articles | October 14, 2024
Articles | September 13, 2024
Blog | September 04, 2024
Articles | August 26, 2024
Articles | August 24, 2024
Blog | August 19, 2024
Articles | July 12, 2024
Articles | June 20, 2024
Blog | June 14, 2024
Articles | June 2024
Articles | May 2024
Articles | May 08, 2024
Blog | April 11, 2024
Blog | March 20, 2024
Blog | February 20, 2024
Articles | Winter/Spring 2024
Articles | February 07, 2024
Articles | January 10, 2024
Articles | January 01, 2024
Blog | December 28, 2023
Blog | December 27, 2023
Articles | December 18, 2023
Articles | December 2023
Articles | September 01, 2023
Blog | August 28, 2023
Blog | August 15, 2023
Articles | July 03, 2023
Blog | June 22, 2023
Articles | June 02, 2023
Articles | June 2023
Blog | May 17, 2023
Blog | March 22, 2023
Blog | March 13, 2023
Articles | March 03, 2023
Blog | February 24, 2023
Articles | January 31, 2023
Articles | January 27, 2023
Webinar | May 13, 2025
Drug Diversion Controls
Speaking Engagements | February 20-21, 2025
Speaking Engagements | January 27, 2023
Media Mentions | August 05, 2025
Media Mentions | July 22, 2025
Media Mentions | July 17, 2025
Media Mentions | March 25, 2025
Media Mentions | January 26, 2025
Media Mentions | October 22, 2024
Media Mentions | August 27, 2024
Media Mentions | July 30, 2024
Media Mentions | May 01, 2024
Media Mentions | February 22, 2024
Media Mentions | July 31, 2023
Media Mentions | June 23, 2023
Media Mentions | June 13, 2023
Media Mentions | May 08, 2023
Media Mentions | February 02, 2023